Legislation & Regulation

Discover essential legislative and regulatory resources tailored for managed care pharmacy professionals. Stay informed with the latest updates, policies, and advocacy tools to effectively navigate and influence the health care landscape.

Learn More

Legislative & Regulatory Briefings

October 2023 Legislative & Regulatory Briefing

October 2023 Legislative & Regulatory Briefing: Now Available: “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy”; AMCP Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plan; AMCP Makes Headlines on PDTs, Nexus 2023; BBCIC Awarded $1.4 Million Grant From the FDA; AMCP Comments on Medicaid Program; Misclassification of Drugs, Program Administration, and Program Integrity Updates Under the Medicaid Drug Rebate Program.
Legislation & Regulation
AMCP Caragon
Legislative & Regulatory Briefings

October 2023 Legislative & Regulatory Briefing

October 2023 Legislative & Regulatory Briefing: Now Available: “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy”; AMCP Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plan; AMCP Makes Headlines on PDTs, Nexus 2023; BBCIC Awarded $1.4 Million Grant From the FDA; AMCP Comments on Medicaid Program; Misclassification of Drugs, Program Administration, and Program Integrity Updates Under the Medicaid Drug Rebate Program.
Legislation & Regulation
AMCP 2023 Value of Managed Care Pharmacy Report
Resource

The Value of Managed Care Pharmacy

Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.
Biosimilars, Prescription Digital Therapeutics, Formulary & Utilization Management, Health Disparities, Health Technology, Legislation & Regulation, Managed Care Practice Issues
Letters, Statements & Analysis

AMCP Comment on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans

On August 21, 2023, CMS Issued the Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plans: Draft Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025. The purpose of this document is to provide interested parties with draft part one guidance on a select set of topics for the Maximum Monthly Cap on Cost-Sharing Payments Program.
Legislation & Regulation
Legislative & Regulatory Briefings

September 2023 Legislative & Regulatory Briefing

September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.
Legislation & Regulation
AMCP Caragon
Legislative & Regulatory Briefings

September 2023 Legislative & Regulatory Briefing

September 2023 Legislative & Regulatory Briefing: Access to PDTs Act of 2023 Discussed in a House Energy & Committee Hearing; AMCP Comments on Coverage with Evidence Development Proposed Guidance; Adam Colborn Discusses AMCP’s Legislative & Regulatory Priorities for 2023; Now Available: AMCP’s Inflation Reduction Act Resource Center; 2023 Call for AMCP Committee Applications Now Open.
Legislation & Regulation
Legislative & Regulatory Briefings

July 2023 Legislative & Regulatory Briefing

July 2023 Legislative & Regulatory Briefing: Tell Congress to Pass the MVP Act of 2023; AMCP Gathers PDT Manufacturers for Product Demonstrations on Capitol Hill; AMCP’s Adam Colborn Discusses Biosimilar Interchangeability with AJMC; Register for the Inflation Reduction Act Pre-Conference Program at AMCP Nexus 2023; Catch Up on the Latest Regulatory NewsBREAKs.
Legislation & Regulation